Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

Researchers developed a mouse model that successfully mimics the bladder damage seen in humans after radiation therapy.

Injecting alpha-melanocyte-stimulating hormone in mice improved skin healing and reduced scarring.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Dogs could be good models for studying human hair growth and hair loss.

Cell-based therapies show promise for treating Limbal Stem Cell Deficiency but need more research.

Gene therapy, especially using atoh1, shows promise for creating functional sensory hair cells in the inner ear, but dosing and side effects need to be managed for clinical application.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Trichodynia is a painful scalp condition linked to hair loss and inflammation, often with anxiety, affecting more women and needing better treatment options.

Using neurohormones to control keratin can lead to new skin disease treatments.

The regenerative solution, tSVF, is a safe and effective treatment for various conditions like aged skin, scars, wounds, and more, but more research is needed to find the best way to use it.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Skin-derived stem cells can become various cell types, including germ cell-like and oocyte-like cells.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Scientists made skin stem cells from other human cells with over 97% efficiency, which could help treat skin conditions.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Moderately high prolactin levels do not cause hair loss in women.

Some chemicals absorbed through the skin can cause serious health problems.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.